| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/27/2002 | US20020081334 Preparation of drug particles using evaporation precipitation into aqueous solutions |
| 06/27/2002 | US20020081333 Orally administrable opioid formulations having extended duration of effect |
| 06/27/2002 | US20020081332 Rate controlling polymers are present at amounts of .1-4.0% w/w |
| 06/27/2002 | US20020081331 Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| 06/27/2002 | US20020081328 Zinc chloride unit dose packaging, applicator, and method of use in treating cancer and other skin diseases |
| 06/27/2002 | US20020081315 Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 06/27/2002 | US20020081292 Anthelmintic composition |
| 06/27/2002 | US20020081289 Ophthalmic medicament |
| 06/27/2002 | US20020081267 Toothpaste, gel, or mouthwash comprising emulsifier, triclosan, and surfactant (cetylpyridinium chloride); anticaries agents |
| 06/27/2002 | US20020081266 Spray dried powders for pulmonary or nasal administration |
| 06/27/2002 | US20020081265 Composition for treatment of a bacterial infection of the upper respiratory tract |
| 06/27/2002 | US20020081264 Expanded perborate salt, use, and method of production |
| 06/27/2002 | US20020079476 Applications and devices based on nanostructured non-stoichiometric substances |
| 06/27/2002 | US20020078948 Method for generating an aerosol |
| 06/27/2002 | DE10131641A1 St. John's wort extracts having reduced chlorophyll and proanthocyanidin contents, useful as topical medicaments, e.g. for treating stomatitis, acne, viral infections or psoriasis |
| 06/27/2002 | DE10125261A1 Medikamentenpumpe mit bündig zu der äußeren Oberfläche abschließenden Vernähschlaufe Drug pump with flush with the outer surface of the final seaming |
| 06/27/2002 | DE10064387A1 Redispersible dry powder containing oxygen-containing carotenoid, useful e.g. as dye in foods, feed or pharmaceuticals, prepared in presence of partially degraded soya protein as protective colloid |
| 06/27/2002 | CA2756207A1 Compositions of estrogen-cyclodextrin complexes |
| 06/27/2002 | CA2442181A1 Method for purification of lactose |
| 06/27/2002 | CA2436149A1 Novel in-situ forming controlled release microcarrier delivery system |
| 06/27/2002 | CA2432879A1 Anti-allergic complex molecules |
| 06/27/2002 | CA2432839A1 Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate |
| 06/27/2002 | CA2432797A1 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 06/27/2002 | CA2432638A1 Therapeutic combination of amlodipine and benazepril |
| 06/27/2002 | CA2432282A1 Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 06/27/2002 | CA2431740A1 A method to enhance the immune system and used for the prevention and treatment of infectious diseases |
| 06/27/2002 | CA2423331A1 Shark meat extract |
| 06/27/2002 | CA2397990A1 Propofol formulation with enhanced microbial inhibition |
| 06/26/2002 | EP1216748A1 Method and apparatus for forming composite pellets |
| 06/26/2002 | EP1216706A2 Enteral composition for stimulating the immune system |
| 06/26/2002 | EP1216704A1 Controlled release valproate composition |
| 06/26/2002 | EP1216703A2 Thiocarbamate sulfoxide composition for deterring ethanol ingestion |
| 06/26/2002 | EP1216700A1 Transdermal systems comprising (R)-(-)-methylphenyloxazolidinone derivatives, inhibitors of type IV phosphodiesterase |
| 06/26/2002 | EP1216699A1 Transdermal system comprising a highly potent progestin |
| 06/26/2002 | EP1216695A2 O/W Emulsions comprising a copolymer of ammonium acryloyl dimethyl taurate and vinylpyrrolidone |
| 06/26/2002 | EP1216686A2 Gel-creams of the o/w emulsion type containing one or more ammonium acryloyl dimethyltaurate/vinyl pyrrolidone copolymers |
| 06/26/2002 | EP1216091A1 Method for encapsulating active substances by coacervation of polymers in non-chlorinated organic solvent |
| 06/26/2002 | EP1216065A1 Silver-containing compositions, devices and methods for making |
| 06/26/2002 | EP1216058A2 Process for lessening polymorphic conversion of a drug |
| 06/26/2002 | EP1216057A1 Stable calcitriol solution for packaging in vials |
| 06/26/2002 | EP1216053A2 Influenza vaccine |
| 06/26/2002 | EP1216048A2 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols |
| 06/26/2002 | EP1216047A2 Novel combination of loteprednol and beta2-adrenoceptor agonists |
| 06/26/2002 | EP1216045A2 Vasopressin agonist formulation and process |
| 06/26/2002 | EP1216044A1 Compositions having improved stability |
| 06/26/2002 | EP1216043A1 Retard form containing alpha-lipoic acid (derivatives) |
| 06/26/2002 | EP1216042A1 Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles |
| 06/26/2002 | EP1216037A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 06/26/2002 | EP1216036A1 Transdermal administration of n-(2,5-disubstituted phenyl)-n'-(3-substituted phenyl)-n'-methyl guanidines |
| 06/26/2002 | EP1216035A2 Preparation containing active ingredients and/or auxiliary agents with a controlled release of these substances and the use and production of the same |
| 06/26/2002 | EP1216034A2 Method and device for dispensing adhesive laminate segments from a movable primary support sheet situated on a secondary support sheet |
| 06/26/2002 | EP1216033A1 Vasopressin antagonist formulation and process |
| 06/26/2002 | EP1216032A1 Oral controlled release formulations |
| 06/26/2002 | EP1216031A2 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 06/26/2002 | EP1216030A1 Anti-inflammatory pharmaceutical formulations |
| 06/26/2002 | EP1216029A1 Pharmaceutical carrier formulation |
| 06/26/2002 | EP1216028A1 Biodegradable excipient systems for therapeutically active substances and method for producing the same |
| 06/26/2002 | EP1216027A2 Pharmaceutical composition in the form of a nucleic acid lipid complex, the production thereof and its use in gene therapy |
| 06/26/2002 | EP1216026A1 Compositions of tocol-soluble therapeutics |
| 06/26/2002 | EP1216025A1 Dispersion formulations containing lipase inhibitors |
| 06/26/2002 | EP1216024A1 Formulation for menopausal women |
| 06/26/2002 | EP1215963A2 Methods for treating neuropathic pain using hetreoarylmethanesulfonamides |
| 06/26/2002 | EP1083945B1 Encapsulation devices with strand, yarn or mesh core |
| 06/26/2002 | EP1073414B1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 06/26/2002 | EP1058538B1 Fast disintegrating tablets |
| 06/26/2002 | EP1051155B1 Nasal solutions |
| 06/26/2002 | EP1037609A4 Aqueous insecticidal pour-on formulation |
| 06/26/2002 | EP1007011A4 Lock and key micelles |
| 06/26/2002 | EP0973506B1 Process for preparing solid pharmaceutical dosage forms |
| 06/26/2002 | EP0971718B1 Combined preparation for oral application of erythromycins |
| 06/26/2002 | EP0941065B1 Ionophore-mediated liposome loading of weakly basic drug |
| 06/26/2002 | EP0930878B1 Use of sodium 2-mercaptoethanesulfonate in surgery |
| 06/26/2002 | EP0896530B1 Dosage forms and uses |
| 06/26/2002 | EP0850049B1 Composition for ph-dependent controlled release of active ingredients and methods for producing it |
| 06/26/2002 | EP0783296B1 Novel compositions for the introduction of polyanionic materials into cells |
| 06/26/2002 | EP0734722B1 Percutaneous administration patch medicine |
| 06/26/2002 | CN2496459Y Green ear acupuncture point puster |
| 06/26/2002 | CN1355846A Method for down-regulating IL5 activity |
| 06/26/2002 | CN1355813A Peptide having preptin functionality |
| 06/26/2002 | CN1355713A Releasable bond and composition containing said bond |
| 06/26/2002 | CN1355710A Combination vaccine against streptocouus pneumoniae and repiratory syncytial virus (RSV) |
| 06/26/2002 | CN1355704A Method for preparing membrane visicles |
| 06/26/2002 | CN1355695A Compounds useful in reducing level of insulin like growth factor-I (IGF-I) in blood |
| 06/26/2002 | CN1355694A Measalazine controlled redease oral pharmaceutical compositions |
| 06/26/2002 | CN1355693A Controlled release and taste masking oral pharmaceutical compositions |
| 06/26/2002 | CN1355692A Taste masked compositions |
| 06/26/2002 | CN1355691A Antibody and polyalkylene glycol-bonded liposome |
| 06/26/2002 | CN1355690A Method for improving half-life of soluble viral-specific ligands on mucosal membranes |
| 06/26/2002 | CN1355036A Ointment for treating ostalgia and its preparing process |
| 06/26/2002 | CN1355021A Percutaneous medicine of strychnine (toxiferine or securinine) and salt thereof |
| 06/26/2002 | CN1355020A Process for preparing immobilized composite vitamines capsule |
| 06/26/2002 | CN1355019A Process for preparing nano-class Chinese medicine powder |
| 06/26/2002 | CN1355018A Process for preparing micron-class of Chinese-medicinal material |
| 06/26/2002 | CN1355017A Process for preparing micro-class extract of Chinese-medicinal material |
| 06/26/2002 | CN1355016A Process for preparing micron-class Chinese-medicinal materials |
| 06/26/2002 | CN1355015A Application of liposome preparation in transferring foreign DNA by testis injection |
| 06/26/2002 | CN1355014A Process for preparing medicine to treat rhinitis, nasosinusitis and frontal sinusitis by spraying it into nose or exterior application and its application |
| 06/26/2002 | CN1355011A Long-acting hair fixing mousse |
| 06/26/2002 | CN1086728C Antioxidant-containing blowing agent |
| 06/26/2002 | CN1086589C Vaccines |